In a significant development, the process to sell a controlling stake in Universal Nutriscience, a pure play nutraceuticals platform backed by Kedaara Capital, has reached its next stage. British consumer healthcare player Haleon, along with several leading private equity firms, has been shortlisted to proceed further in the sale process. This move indicates the strong interest from prominent players in the industry to acquire a stake in Universal Nutriscience, which was formed in June 2021 through a joint effort by Kedaara Capital and Universal Medicare to purchase the nutraceutical business of Sanofi India. The formation of Universal Nutriscience was a strategic move aimed at expanding the presence of Kedaara Capital in the Indian nutraceuticals market, which has been witnessing significant growth in recent years. The company's focus on providing high-quality nutraceutical products has enabled it to establish a strong foothold in the market, making it an attractive target for potential investors. The shortlisting of Haleon and private equity firms for the next stage of the sale process is expected to drive further growth and expansion of Universal Nutriscience in the Indian market. The Indian nutraceuticals market has been growing rapidly, driven by increasing awareness about health and wellness among consumers, and the acquisition of Universal Nutriscience is likely to provide a significant boost to the buyer's presence in this market. The sale process is expected to be highly competitive, with several prominent players vying for a stake in the company. As the process moves forward, it will be interesting to see which player ultimately emerges as the successful bidder. The outcome of the sale process is likely to have significant implications for the Indian nutraceuticals market, with the potential for further consolidation and growth in the sector. The involvement of prominent players like Haleon and private equity firms is expected to drive innovation and expansion in the market, ultimately benefiting consumers through the availability of high-quality products.
Haleon, top PE’s picked for next stage

Key Points
- Haleon and top private equity firms have been shortlisted for the next stage in the sale of a controlling stake in Universal Nutriscience
- Universal Nutriscience was formed in June 2021 through a joint effort by Kedaara Capital and Universal Medicare to purchase the nutraceutical business of Sanofi India
- The Indian nutraceuticals market has been growing rapidly, driven by increasing awareness about health and wellness among consumers
- The sale process is expected to be highly competitive, with several prominent players vying for a stake in the company
- The outcome of the sale process is likely to have significant implications for the Indian nutraceuticals market, with the potential for further consolidation and growth in the sector
CJPN24 AI Desk
ai agent
AI-assisted news desk. All content is editorially reviewed before publication.
Comments
Comments section coming soon. Share your thoughts on our social media pages.